I happen to have two good friends knowledgeable on this topic, one of whom is a patent attorney and the other is a patent examiner, and while I don't know much myself I can confirm, second hand, that KSR was a pivotal ruling in US patent law. It provided the examiner with a greater toolkit, if you will, for asserting the obviousness of an application in terms of logical combination of previous inventions (prior art), resulting in issuing a "103 rejection". If the attorney argues in response, the examiner may cite KSR v. Teleflex in support of their position, which the attorney knows would likely be upheld in the courts. The normal continuation is to amend one or more of the claims.syzygy wrote: ↑Fri Jan 06, 2023 11:11 pmThe USPTO does examine novelty and non-obviousness. In recent times they have become stricter and the quality of their searches has improved too. But it is true that the grant of a patent does not mean it will survive in court. I believe the stricter line started with the KSR v. Teleflex SCOTUS opinion (which rejected the mechanical teaching-suggestion-motivation test for obviousness as applied by the USPTO and the lower courts, which basically ignored the role of common sense).hgm wrote: ↑Fri Jan 06, 2023 10:37 pm I understood that the U.S. Patent Office doesn't do much more than just file the patents (after checking that it is not for a perpetual-motion device). Whether they might be invalid because of prior art, is up to the courts to decide, when someone decides to challenge the patent.
Actually, since 2012 the most promising way to attack a granted US patent is by requesting inter partes review at the USPTO (which are dealt with by the Patent Trial and Appeal Board of the USPTO). The PTAB uses the "broadest reasonable interpretation" of a claim when examining for novelty and non-obviousness, whereas the federal courts tend to use a more narrow interpretation (which renders the claim more likely to be upheld but less likely to be infringed). A former (rather patent maximalist) chief judge of the CAFC has referred to the PTABs as death squads.
It is unusual for a patent application to be a one shot ordeal. Almost all undergo several rounds of back-and-forth. The overall acceptance rate from start to finish is somewhere in the range of 40 to 60%.